Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3305 Target Snapshot

Sex hormone-binding globulin · SINGLE PROTEIN · Homo sapiens

179Compounds
33Assays
17Approved Drugs
107.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P04278. Use UniProt P04278 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P04278 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sex hormone-binding globulin as ChEMBL target CHEMBL3305, mapped to UniProt P04278. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sex hormone-binding globulin
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3305
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P04278
Sex hormone-binding globulin
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sex hormone-binding globulin is the right protein anchor across sources, using UniProt P04278 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSex hormone-binding globulin
UniProt AccessionP04278
Component TypeProtein
Sequence Length402 aa

Sex hormone-binding globulin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sex hormone-binding globulin, mapped to UniProt P04278. Sequence length is 402 aa.

Mapped IDP04278
Review nameSex hormone-binding globulin
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

17
Approved
4
Phase III
11
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5014.0
KI1.0
KD92.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL260202 9.74 Kd 0.182 Preclinical
CHEMBL27769 9.74 Kd 0.182 Clinical
CHEMBL258918 9.6 Kd 0.2512 Clinical
CHEMBL259126 9.54 Kd 0.2884 Preclinical
CHEMBL411053 9.38 Kd 0.4169 Preclinical
CHEMBL265926 9.32 Kd 0.4786 Preclinical
CHEMBL265925 9.31 Kd 0.4898 Preclinical
CHEMBL386630 9.2 Kd 0.631 Approved
CHEMBL440283 9.17 Kd 0.6761 Preclinical
CHEMBL260660 9.12 Kd 0.7586 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
8
5.5
14
6.0
8
6.5
7
7.0
8
7.5
16
8.0
14
8.5
13
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

ETONOGESTREL
CHEMBL1531
Approved 2001
ESTRIOL
CHEMBL193482
Approved 2000
DESOGESTREL
CHEMBL1533
Approved 1992
ETHINYL ESTRADIOL
CHEMBL691
Approved 1982
ESTRONE
CHEMBL1405
Approved 1979
DANAZOL
CHEMBL1479
Approved 1976
PROGESTERONE
CHEMBL103
Approved 1976
ESTRADIOL
CHEMBL135
Approved 1975
METHYLTESTOSTERONE
CHEMBL1395
Approved 1973
TESTOSTERONE
CHEMBL386630
Approved 1972
NORGESTREL
CHEMBL2107797
Approved 1968
NORETHINDRONE
CHEMBL1162
Approved 1962
MEDROXYPROGESTERONE ACETATE
CHEMBL717
Approved 1959
HYDROCORTISONE
CHEMBL389621
Approved 1952
Assay Landscape

Assay Landscape

34
Total Assays
100
Tested Compounds
3
Assay Types
Binding — 26 assays, 100 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 26 100 7.4
ADME — 7 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 7 1 7.8
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 8.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine